Research Rounds
Join us for the Gynecologic Cancer Initiative Research Rounds! The Gynecologic Cancer Initiative Research Rounds features researchers working on accelerating transformative research on prevention, treatment and survivorship of gynecologic cancers. The goal of these research rounds is to provide a forum for researchers, trainees and staff to learn about the range of different gynecologic cancer research projects happening across British Columbia.
All researchers, clinicians, trainees, and staff members are welcome to join!
Please note that you must register to attend these research rounds. Meeting details will be sent out to registrants before the event. Light refreshments will be provided to in-person attendees!
2023 – 2024 Research Rounds
February 6, 2024
Leveraging array-based DNA methylation analysis for gynecologic cancer research and diagnostics
Dr. Felix Kommoss
January 29, 2024
Striving for a better understanding of vulvar cancer
Dr. Lois Eva
January 26, 2024
Real-world experiences of first-line maintenance PARP inhibitor treatment in non-BRCA mutant high-grade serous ovarian cancer
Dr. Nicola Hannaway
December 8, 2023
Discovery of HPV-Associated Genomic Alterations in Cervical Cancer
Vanessa Porter
November 24th, 2023
Exploring the Full Potential of PARP Inhibitors in Ovarian Cancer, and Other Pursuits of the Clinical Researcher
Dr. Anna Tinker
November 10th, 2023
Peritumoral Stromal Remodelling and Ontogenetic Spread of Uterine Cervical Cancer
Dr. Lars-Christian Horn
October 16, 2023
From Atypical Hyperplasia to Endometrial Carcinoma: Unravelling Molecular Subtypes and Histological Transformations
Dr. Jutta Huvila
September 29, 2023
Telomerase non-canonical function in DNA damage response in the context of high-grade serous ovarian cancer
Kat Nguyen
2022 – 2023 Research Rounds
May 26, 2023 | 12 – 1pm PST
Pathology AI in Gynecological Cancers: Current Advances and Future Directions
Dr. Ali Bashashati
April 14, 2023
The continuing evolution of endometrial carcinoma molecular classification
Dr. Amy Jamieson
March 31, 2023
Opportunistic salpingectomy during caesarean section: Detailing the safety to improve uptake of OS for sterilization
Dr. Gillian Hanley & Khaye Rufin
February 17, 2023
Defining targetable vulnerabilities in small cell carcinoma of the ovary hypercalcemic type: a journey from genomic discovery to therapeutic development
Dr. Yemin Wang
January 27, 2023
Evaluating patient adherence, satisfaction and out-of-pocket expense following implementation of offering an oral option for post-operative venous thromboembolic prophylaxis after Gynecologic Oncology surgery
Dr. Kimberly Stewart
December 9, 2022
Clinical phenotyping of KRAS somatic mutations in endometriosis
Dr. Paul Yong
November 18, 2022
Podocalyxin in High Grade Serous Ovarian Carcinoma
Dr. Calvin Roskelley
October 28, 2022
Long Term Colposcopy Referral Rates after the Introduction of HPV-based Cervix Screening
Dr. Anna Gottschlich
2021-2022 Research Rounds Recordings
Targeting the DNA damage response in gynaecological cancers beyond PARP inhibitors
Dr. Yvette Drew
Deciphering and re-engineering the immune response to gynecological cancers
Dr. Brad Nelson
Genetic testing initiatives in ovarian cancer
ffgdgfgdfdfhddhdfgdfg
Dr. Janice Kwon
Cultural safety in reproductive health and being an ally
hbjkhkj
Dr. Unjali Malhotra
Application of machine learning to predict recurrence in high grade endometrial cancer
Dr. Sabrina Piedimonte
Vulvar cancer: more than meets
the eye
hfghgfh
Dr. Lynn Hoang
Is Worldview a Cervical Cancer Risk?: Challenging Settler Paradigms for Indigenous Health Research
sdfsfds
Dr. Sheona Mitchell-Foster
The Value and impact of supportive cancer care
hbjkhkj
sfsdfsd
Dr. Hannah Nette
The ELECTRA journey – The challenges of bringing molecular classification of endometrial carcinoma into routine diagnostic practice
Dr. Naveena Singh
How to address frailty and low physical function in women with early stage and advanced cancers
Dr. Kristen Campbell
Therapeutic advancement and biomarker discovery in women’s cancers: Research models and strategies
Dr. Mark Carey
Advances in interstitial gyne brachytherapy in BC
Dr. Francois Bachand
2020-2021 Research Rounds Recordings
Drugs targeting to tumors in the peritoneal cavity
Dr. Shyh-Dar Li, PhD
Hereditary gynceologic cancers: testing, prevention and management
Dr. Lesa Dawson, MD, FRCSC
Metabolism, cancer and the immune system – what do they have in common?
Dr. Julian Lum, PhD
Heterogeneity and molecular subtypes in endometriosis-associated cancers and their precursors
Dr. Michael Anglesio, PhD
Strategies for making an impact with policy makers: Methods from women’s health research
Dr. Sarah Munro, PhD
What’s new in the classification of gynecological cancers: the 5th edition of the WHO guidelines
Dr. Blake Gilks, MD
Clinical prediction
models in
gynecological oncology
Dr. Aline Talhouk, PhD
Real-life patient
experiences in
gynecologic oncology
Dr. Jenny Ko, MD
Where are the knowledge gaps to get us to cervical cancer elimination in women living with HIV?
Dr. Deborah Money, MD Dr. Elisabeth McClymont, PhD
Opportunistic salpingectomy for ovarian cancer prevention and age of onset of menopause: Reassuring findings from British Columbia
Dr. Gillian Hanley, PhD
New data on POLEmut and NSMMP molecular subtypes of endometrial cancer and how molecular classification is changing EC management today
Dr. Jessica McAlpine, MD
Ovarian cancer subtypes reframed as distinct oncogenic journeys: a post-genomic approach to research
Dr. David Huntsman, MD
